CD80 and neoplasm: Additionally, we found that, compared to sham controls, CD45hi/CD11bhi cells from tumor-bearing mice exhibited upregulated expression of several immune checkpoints, including VISTA, CD80, PD-L1, and CTLA-4 but not Tim-3 (Figure 2c).